CORC

在结果中检索

CORC

浏览/检索结果: 共19条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Chronic graft-versus-host disease-related polymyositis and myocarditis: A case report and review of the literature 期刊论文
TRANSPLANT IMMUNOLOGY, 2022, 卷号: 72
作者:  Yan, Mengni;  Su, Fengqin;  Cheng, Fei;  Shi, Jimin;  Zheng, Weiyan
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Janus Kinase Inhibitors: A Review of Their Application in the Vitiligo 期刊论文
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 卷号: 21, 期号: 20, 页码: 3203-3218
作者:  Niu, C (Niu, Chao) [1] , [2] , [3] , [4];  Xie, HJ (Xie, Huijun) [1] , [2] , [3];  Aisa, HA (Aisa, Haji Akber) [1] , [2] , [3]
收藏  |  浏览/下载：24/0  |  提交时间：2022/03/24
A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway 期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5, 期号: 1, 页码: 11
作者:  Lu, Kang;  Li, Bo;  Zhang, Hui;  Xu, Zhijian;  Song, Dongliang
收藏  |  浏览/下载：56/0  |  提交时间：2020/07/01
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 8, 页码: 3898-3923
作者:  Liang, Xuewu;  Zang, Jie;  Li, Xiaoyang;  Tang, Shuai;  Huang, Min
收藏  |  浏览/下载：18/0  |  提交时间：2020/07/01
Cotargeting the JAK/STAT signaling pathway and histone deacetylase by ruxolitinib and vorinostat elicits synergistic effects against myeloproliferative neoplasms 期刊论文
2019
作者:  Hao Xing;  Xing Wen;  Yuan Jiajia;  Wang Yingshao;  Bai Jiaojiao
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Improvement of the hematologic toxicities of ruxolitinib in patients with MPN-associated myelofibrosis using a combination of thalidomide, stanozolol and prednisone 期刊论文
2019, 卷号: 24, 期号: 1, 页码: 516-520
作者:  Duan, Minghui;  Zhou, Daobin
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis 期刊论文
2019, 卷号: 104, 期号: 5, 页码: 947-954
作者:  Vannucchi, Alessandro M.;  te Boekhorst, Peter A. W.;  Harrison, Claire N.;  He, Guangsheng;  Caramella, Marianna
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells. 期刊论文
Leukemia & Lymphoma, 2018, 卷号: Vol.59 No.1, 页码: 196-203
作者:  Cheng, Zhiyong;  Fu, Jianzhu;  Liu, Guimin;  Zhang, Lijun;  Xu, Qian
收藏  |  浏览/下载：3/0  |  提交时间：2019/03/26
Ruxolitinib在制备治疗M2型急性髓系白血病药物中的应用 专利
申请日期: 2017-01-01,
作者:  刘立根;  庄晏
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
RUXOLITINIB/NILOTINIB COTREATMENT BETTER INHIBITS LEUKEMIA-PROPAGATING CELLS IN PHILADELPHIA CHROMOSOME-POSITIVE ALL 期刊论文
HAEMATOLOGICA, 2017
Kong, Y.; Wu, Y.L.; Song, Y.; Shi, M.M.; Cao, X.N.; Zhao, H.Y.; Qin, Y.Z.; Lai, Y.Y.; Jiang, H.; Jiang, Q.; Huang, X.J.
收藏  |  浏览/下载：4/0  |  提交时间：2017/12/03

©版权所有 ©2017 CSpace - Powered by CSpace